Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Neoplasms 93Breast Neoplasms 79Lung Neoplasms 50Prostatic Neoplasms 45Colorectal Neoplasms 33Carcinoma, Non-Small-Cell Lung 31Pancreatic Neoplasms 29Hematologic Neoplasms 22Lymphoma 19Brain Neoplasms 19Stomach Neoplasms 17Ovarian Neoplasms 17Urinary Bladder Neoplasms 15Multiple Myeloma 14Melanoma 14Liver Neoplasms 14Leukemia, Myeloid, Acute 14Head and Neck Neoplasms 13Esophageal Neoplasms 13Carcinoma, Hepatocellular 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Leukemia 12Disease 12Carcinoma, Renal Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 11Kidney Neoplasms 11Colonic Neoplasms 11Glioma 10

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pyruvate Kinase Deficiency of Red Cells × 30 days × Clear all
NCT04902833 2026-05-19

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Massachusetts General Hospital

Completed
18 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Pyruvate Kinase Deficiency of Red Cells, Anemia, Hemolytic, Congenital, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡